. .. Conclusion,

. .. Liste-des-tableaux,

. .. Bibliographie,

. .. Annexes,

, Bibliographie 1. Institut pasteur (Septembre 2014) Sepsis-Septicémie

. Disponible-À-partir-de,

R. P. Dellinger, M. M. Levy, A. Rhodes, D. Annane, H. Gerlach et al., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Intensive Care Med, vol.39, issue.2, pp.165-228, 2012.

M. Singer, C. S. Deutschman, and C. Seymour, THe third international consensus definitions for sepsis and septic shock (sepsis-3), JAMA, vol.315, issue.8, pp.801-811, 2016.

E. Wiel, P. Gosselin, and J. Levraut, Choc septique : du préhospitalier à l'admission en réanimation, Actualités en médecine d'urgence : Urgences vitales et infectiologie Journées Thématiques Interactives de la SFMU Dijon 2013. Société Française d'Editions Médicales, 2014.

D. C. Angus and T. Van-der-poll, Severe Sepsis and Septic Shock, N Engl J Med, vol.369, issue.9, pp.840-51, 2013.

W. J. Wiersinga, S. J. Leopold, and D. R. Cranendonk, Poll T van der. Host innate immune responses to sepsis, Virulence, vol.5, issue.1, pp.36-44, 2014.

R. S. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nat Rev Immunol, vol.13, issue.12, p.862, 2013.

K. N. Iskander, M. F. Osuchowski, D. J. Stearns-kurosawa, S. Kurosawa, D. Stepien et al., Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding, Physiol Rev, vol.93, issue.3, pp.1247-88, 2013.

H. R. Wong, N. Z. Cvijanovich, N. Anas, G. L. Allen, N. J. Thomas et al., Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock, Am J Respir Crit Care Med, vol.191, issue.3, pp.309-324, 2009.

R. J. Langley, E. L. Tsalik, J. C. Velkinburgh, . Van, S. W. Glickman et al., An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis, Sci Transl Med, vol.5, pp.195-95, 0195.

R. C. Bone, R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein et al., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, The ACCP/SCCM Consensus Conference Committee, vol.101, pp.1644-1655, 1992.

M. M. Churpek, F. J. Zadravecz, C. Winslow, M. D. Howell, and D. P. Edelson, Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients, Am J Respir Crit Care Med, vol.192, issue.8, pp.958-64, 2009.

K. Kaukonen, M. Bailey, D. Pilcher, D. J. Cooper, and R. Bellomo, Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis, N Engl J Med, vol.372, issue.17, pp.1629-1667, 2015.

Á. Castellanos-ortega, B. Suberviola, L. A. García-astudillo, M. S. Holanda, F. Ortiz et al., Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study*, Crit Care Med, vol.38, issue.4, pp.1036-1043, 2010.

P. Y. Gueugniaud, C. Macabeo, J. Ruiz, and M. Zeghari, Catécholamines dans les états de choc. Médecine D?urgence 43e Congrès Natl D?anesthésie Réanimation, 2001.

S. F. Réanimation, Antibiothérapie probabiliste des états septiques graves, Annales francaises d'anesthesie et de reanimation, pp.1020-1026, 2004.

J. Teboul and E. , Recommandations d'experts de la SRLF« Indicateurs du remplissage vasculaire au cours de l'insuffisance circulatoire ». Réanimation, vol.13, pp.255-63, 2004.

E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin et al., Early goaldirected therapy in the treatment of severe sepsis and septic shock, N Engl J Med, vol.345, pp.1368-1377, 2001.

W. Gu, F. Wang, J. Bakker, L. Tang, and J. Liu, The effect of goal-directed therapy on mortality in patients with sepsis-earlier is better: a meta-analysis of randomized controlled trials, Crit Care, vol.18, p.570, 2014.

M. A. Puskarich, M. R. Marchick, J. A. Kline, M. T. Steuerwald, and A. E. Jones, One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study, Crit Care, vol.13, issue.5, p.167, 2009.

F. Sebat, D. Johnson, A. A. Musthafa, M. Watnik, S. Moore et al., A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients, Chest, vol.127, issue.5, pp.1729-1743, 2005.

P. K. Gurnani, G. P. Patel, C. W. Crank, D. Vais, O. Lateef et al., Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study, Clin Ther, vol.32, issue.7, pp.1285-1293, 2010.

M. M. Levy, R. P. Dellinger, S. R. Townsend, W. T. Linde-zwirble, J. C. Marshall et al., The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis, Intensive Care Med, vol.36, issue.2, pp.222-231, 2010.

O. 'neill, R. Morales, J. , and J. M. , Early Goal-directed Therapy (EGDT) for severe sepsis/septic shock: which components of treatment are more difficult to implement in a community-based emergency department?, J Emerg Med, vol.42, issue.5, pp.503-510, 2012.

J. Contenti, H. Corraze, F. Lemoël, and J. Levraut, Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients, Am J Emerg Med, 2014.

K. E. Hodgin and M. Moss, The epidemiology of sepsis, Curr Pharm Des, vol.14, pp.1833-1842, 2008.

S. Trzeciak, R. P. Dellinger, N. L. Abate, R. M. Cowan, M. Stauss et al., Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department, CHEST J, vol.129, issue.2, pp.225-232, 2006.

K. Reinhart, H. Kuhn, C. Hartog, and D. L. Bredle, Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill, Intensive Care Med, 2004.

B. J. Wilson, H. J. Cowan, J. A. Lord, D. J. Zuege, and D. A. Zygun, The accuracy of pulse oximetry in emergency department patients with severe sepsis and septic shock: a retrospective cohort study, BMC Emerg Med, vol.10, issue.1, p.9, 2010.

S. M. Hollenberg, T. S. Ahrens, D. Annane, M. E. Astiz, D. B. Chalfin et al., Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update, Crit Care Med, vol.32, issue.9, pp.1928-1948, 2004.

D. Ledoux, M. E. Astiz, C. M. Carpati, and E. C. Rackow, Effects of perfusion pressure on tissue perfusion in septic shock, Crit Care Med, vol.28, issue.8, pp.2729-2732, 2000.

M. Varpula, M. Tallgren, K. Saukkonen, L. Voipio-pulkki, and V. Pettilä, Hemodynamic variables related to outcome in septic shock, Intensive Care Med, vol.31, issue.8, pp.1066-71, 2005.

B. Tavernier, O. Makhotine, G. Lebuffe, J. Dupont, and P. Scherpereel, Systolic pressure variation as a guide to fluid therapy in patients with sepsis-induced hypotension, Anesthesiology, vol.89, issue.6, pp.1313-1321, 1998.

F. De-ric-michard, Changes in arterial pressure during mechanical ventilation, Anesthesiology, vol.103, issue.2, pp.419-447, 2005.

H. Solus-biguenet, M. Fleyfel, B. Tavernier, E. Kipnis, J. Onimus et al., Noninvasive prediction of fluid responsiveness during major hepatic surgery, Br J Anaesth, vol.97, issue.6, pp.808-824, 2006.

S. A. Haydar, E. T. Moore, G. L. Higgins, C. B. Irish, W. B. Owens et al., Effect of bedside ultrasonography on the certainty of physician clinical decisionmaking for septic patients in the emergency department, Ann Emerg Med, vol.60, issue.3, pp.346-358, 2012.

T. C. Jansen, J. Van-bommel, F. J. Schoonderbeek, S. Visser, S. J. Van-der-klooster et al., Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial, Am J Respir Crit Care Med, vol.182, issue.6, pp.752-761, 2010.

A. E. Jones, N. I. Shapiro, S. Trzeciak, R. C. Arnold, H. A. Claremont et al., Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial, Jama, vol.303, issue.8, pp.739-746, 2010.

E. J. Gallagher, K. Rodriguez, and M. Touger, Agreement between peripheral venous and arterial lactate levels, Ann Emerg Med, vol.29, issue.4, pp.479-483, 1997.

R. F. Lavery, D. H. Livingston, B. J. Tortella, J. T. Sambol, B. M. Slomovitz et al., The utility of venous lactate to triage injured patients in the trauma center, J Am Coll Surg, vol.190, issue.6, pp.656-664, 2000.

J. G. Younger, J. L. Falk, and S. G. Rothrock, Relationship between arterial and peripheral venous lactate levels, Acad Emerg Med, vol.3, issue.7, pp.730-733, 1996.

B. S. Karon, R. Scott, M. F. Burritt, and P. J. Santrach, Comparison of lactate values between pointof-care and central laboratory analyzers, Am J Clin Pathol, vol.128, issue.1, pp.168-171, 2007.

B. Guidet, O. Martinet, T. Boulain, F. Philippart, J. F. Poussel et al., Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study, Crit Care, vol.16, issue.3, p.94, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00706029

F. Schortgen, J. Lacherade, F. Bruneel, I. Cattaneo, F. Hemery et al., Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study, The Lancet, vol.357, issue.9260, pp.911-916, 2001.

L. A. Mcintyre, D. Fergusson, D. J. Cook, N. Rankin, V. Dhingra et al., Fluid resuscitation in the management of early septic shock (FINESS): A randomized controlled feasibility trial, Can J Anesth, vol.55, issue.12, pp.819-826, 2008.

A. Perner, N. Haase, A. B. Guttormsen, J. Tenhunen, G. Klemenzson et al., Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis, N Engl J Med, vol.367, issue.2, pp.124-134, 2012.

J. A. Myburgh, S. Finfer, R. Bellomo, L. Billot, A. Cass et al., Hydroxyethyl starch or saline for fluid resuscitation in intensive care, N Engl J Med, vol.367, issue.20, pp.1901-1911, 2012.

F. M. Brunkhorst, C. Engel, F. Bloos, A. Meier-hellmann, M. Ragaller et al., Intensive insulin therapy and pentastarch resuscitation in severe sepsis, N Engl J Med, vol.358, issue.2, pp.125-139, 2008.

A. P. Delaney, A. Dan, J. Mccaffrey, and S. Finfer, The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis*, Crit Care Med, vol.39, issue.2, pp.386-391, 2011.

S. Finfer, R. Bellomo, N. Boyce, J. French, J. Myburgh et al., A comparison of albumin and saline for fluid resuscitation in the intensive care unit, N Engl J Med, vol.350, issue.22, pp.2247-2256, 2004.

J. A. Myburgh, A. Higgins, A. Jovanovska, J. Lipman, N. Ramakrishnan et al., A comparison of epinephrine and norepinephrine in critically ill patients, Intensive Care Med, vol.34, issue.12, pp.2226-2234, 2008.

D. Backer, D. Biston, P. Devriendt, J. Madl, C. Chochrad et al., Comparison of dopamine and norepinephrine in the treatment of shock, N Engl J Med, vol.362, issue.9, pp.779-789, 2010.

B. Levy, P. Bollaert, C. Charpentier, L. Nace, G. Audibert et al., Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study, Intensive Care Med, vol.23, issue.3, pp.282-287, 1997.

D. Backer, D. Aldecoa, C. Njimi, H. Vincent, and J. , Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*, Crit Care Med, vol.40, issue.3, pp.725-730, 2012.

C. Martin, X. Viviand, M. Leone, and X. Thirion, Effect of norepinephrine on the outcome of septic shock, Crit Care Med, vol.28, issue.8, pp.2758-2765, 2000.

P. Seguin, E. Bellissant, L. Tulzo, Y. Laviolle, B. Lessard et al., Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock, Clin Pharmacol Ther, vol.71, issue.5, pp.381-388, 2002.

S. Zhou, H. Qiu, Y. Huang, Y. Yang, and R. Zheng, Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock, Acta Pharmacol Sin, vol.23, issue.7, pp.654-658, 2002.

G. P. Patel, J. S. Grahe, M. Sperry, S. Singla, E. Elpern et al., Efficacy and safety of dopamine versus norepinephrine in the management of septic shock, Shock, vol.33, issue.4, pp.375-380, 2010.

C. Martin, L. Papazian, G. Perrin, P. Saux, and F. Gouin, Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?, CHEST J, vol.103, issue.6, pp.1826-1831, 1993.

D. Annane, P. Vignon, A. Renault, P. E. Bollaert, C. Charpentier et al., Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: aárandomised trial, Lancet, vol.370, pp.676-684, 2007.

A. Morelli, C. Ertmer, S. Rehberg, M. Lange, A. Orecchioni et al., Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial, Crit Care, vol.12, issue.6, p.143, 2008.

O. 'brien, A. Clapp, L. Singer, and M. , Terlipressin for norepinephrine-resistant septic shock, The Lancet, vol.359, issue.9313, pp.1209-1210, 2002.

J. Albanèse, M. Leone, A. Delmas, and C. Martin, Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study*, Crit Care Med, vol.33, issue.9, pp.1897-1902, 2005.

J. Albanèse, M. Leone, A. Delmas, and C. Martin, Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study*, Crit Care Med, vol.33, issue.9, pp.1897-1902, 2005.

P. E. Marik and M. Mohedin, The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis, Jama, vol.272, issue.17, pp.1354-1357, 1994.

F. Lauzier, B. Lévy, P. Lamarre, and O. Lesur, Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial, Intensive Care Med, vol.32, issue.11, pp.1782-1789, 2006.

J. A. Russell, K. R. Walley, J. Singer, A. C. Gordon, P. C. Hébert et al., Vasopressin versus norepinephrine infusion in patients with septic shock, N Engl J Med, vol.358, issue.9, pp.877-887, 2008.

A. Morelli, C. Ertmer, S. Rehberg, M. Lange, A. Orecchioni et al., Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study, Crit Care, vol.13, issue.4, p.130, 2009.

D. W. Landry, H. R. Levin, E. M. Gallant, R. C. Ashton, S. Seo et al., Vasopressin deficiency contributes to the vasodilation of septic shock, Circulation, vol.95, issue.5, pp.1122-1125, 1997.

T. Sharshar, A. Blanchard, M. Paillard, J. C. Raphael, P. Gajdos et al., Circulating vasopressin levels in septic shock, Crit Care Med, vol.31, issue.6, pp.1752-1758, 2003.

A. Eden, Beneficial effects of short-term vasopressin infusion during severe septic shock, Anesthesiology, vol.96, pp.576-582, 2002.

M. W. Dünser, A. J. Mayr, H. Ulmer, H. Knotzer, G. Sumann et al., Arginine Vasopressin in Advanced Vasodilatory Shock A Prospective, Randomized, Controlled Study, Circulation, vol.107, issue.18, pp.2313-2319, 2003.

C. L. Holmes, B. M. Patel, J. A. Russell, and K. R. Walley, Physiology of vasopressin relevant to management of septic shock, CHEST J, vol.120, issue.3, pp.989-1002, 2001.

R. Bellomo, M. Chapman, S. Finfer, K. Hickling, and J. Myburgh, Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, Lancet, vol.356, issue.9248, pp.2139-2143, 1999.

N. P. Day, N. H. Phu, D. P. Bethell, N. T. Mai, T. T. Chau et al., The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection, The Lancet, vol.348, issue.9022, pp.219-223, 1996.

A. Morelli, C. Ertmer, M. Lange, M. Dünser, S. Rehberg et al., Effects of shortterm simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study ?, Br J Anaesth, vol.100, issue.4, pp.494-503, 2008.

J. A. Kellum and J. M. Decker, Use of dopamine in acute renal failure: a meta-analysis, Crit Care Med, vol.29, issue.8, pp.1526-1531, 2001.

A. Kumar, D. Roberts, K. E. Wood, B. Light, J. E. Parrillo et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Crit Care Med, vol.34, issue.6, pp.1589-1596, 2006.

P. S. Barie, L. J. Hydo, J. Shou, D. H. Larone, and S. R. Eachempati, Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection, Surg Infect, vol.6, issue.1, pp.41-54, 2005.

M. A. Puskarich, S. Trzeciak, N. I. Shapiro, R. C. Arnold, J. M. Horton et al., Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol, Crit Care Med, vol.39, issue.9, p.2066, 2011.

E. Solh, A. A. Akinnusi, M. E. Alsawalha, L. N. Pineda, and L. A. , Outcome of septic shock in older adults after implementation of the sepsis "bundle, J Am Geriatr Soc, vol.56, issue.2, pp.272-278, 2008.

A. V. Barochia, X. Cui, D. Vitberg, A. F. Suffredini, O. Grady et al., Bundled care for septic shock: an analysis of clinical trials, Crit Care Med, vol.38, issue.2, p.668, 2010.

, Antibioguide: référentiel lorrain d'antibiologie en établissement de soins, 2014.

A. Kumar, N. Safdar, S. Kethireddy, and D. Chateau, A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study, Crit Care Med, vol.38, issue.8, pp.1651-1664, 2010.

A. Kumar, R. Zarychanski, B. Light, J. Parrillo, D. Maki et al., Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*, Crit Care Med, vol.38, issue.9, pp.1773-1785, 2010.

S. T. Micek, E. C. Welch, J. Khan, M. Pervez, J. A. Doherty et al., Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: A retrospective analysis, Antimicrob Agents Chemother, vol.54, issue.5, pp.1742-1748, 2010.

M. N. Al-hasan, J. W. Wilson, B. D. Lahr, K. M. Thomsen, J. E. Eckel-passow et al., ?lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli, Antimicrob Agents Chemother, vol.53, issue.4, pp.1386-1394, 2009.

I. Martin-loeches, T. Lisboa, A. Rodriguez, C. Putensen, D. Annane et al., Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia, Intensive Care Med, vol.36, issue.4, pp.612-620, 2010.

A. Rodríguez, A. Mendia, J. Sirvent, F. Barcenilla, M. V. De-la-torre-prados et al., Combination antibiotic therapy improves survival in patients with communityacquired pneumonia and shock*, Crit Care Med, vol.35, issue.6, pp.1493-1498, 2007.

L. M. Baddour, V. L. Yu, K. P. Klugman, C. Feldman, A. Ortqvist et al., Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia, Am J Respir Crit Care Med, vol.170, issue.4, pp.440-444, 2004.
DOI : 10.1164/rccm.200311-1578oc

J. Allo, C. Ginsburg, J. Dhainaut, and Y. Claessens, Fièvre et état de choc : les premières heures de prise en charge, Monographies de la société francophone de médecine d'urgence 2006 : Fièvre et urgences. Edition scientifique L et C

J. Garnacho-montero, M. Sa-borges, J. Sole-violan, F. Barcenilla, A. Escoresca-ortega et al., Optimal management therapy for Pseudomonas aeruginosa ventilatorassociated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*, Crit Care Med, vol.35, issue.8, pp.1888-1895, 2007.

J. H. Rex, T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas et al., Practice guidelines for the treatment of candidiasis, Clin Infect Dis, vol.30, issue.4, pp.662-678, 2000.

. Rafailidis, Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review, Virol J, 2008.
DOI : 10.1186/1743-422x-5-47

URL : https://virologyj.biomedcentral.com/track/pdf/10.1186/1743-422X-5-47

M. Ziemann, B. Sedemund-adib, P. Reiland, P. Schmucker, and H. Hennig, Increased mortality in long-term intensive care patients with active cytomegalovirus infection*, Crit Care Med, vol.36, issue.12, pp.3145-3150, 2008.

M. Annetta, R. Maviglia, R. Proietti, and M. Antonelli, Use of corticosteroids in critically ill septic patients : a review of mechanisms of adrenal insufficiency in sepsis and treatment, Curr Drug Targets, vol.10, issue.9, pp.887-94, 2009.

F. Fourrier, H. Bricard, Y. Cohen, P. Daoud, B. Guidet et al., Corticothérapie au cours du choc septique et du syndrome de détresse respiratoire aiguë, Réanimation Urgences, vol.9, issue.8, pp.597-603, 2000.
DOI : 10.1016/s1164-6756(00)90034-3

D. Annane, E. Bellissant, P. Bollaert, J. Briegel, M. Confalonieri et al., Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review, Jama, vol.301, issue.22, pp.2362-2375, 2009.

D. Annane, V. Sébille, C. Charpentier, P. Bollaert, B. François et al., Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, Jama, vol.288, issue.7, pp.862-871, 2002.

J. Briegel, H. Forst, M. Haller, G. Schelling, E. Kilger et al., Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, doubleblind, single-center study, Crit Care Med, vol.27, issue.4, pp.723-732, 1999.

P. Bollaert, C. Charpentier, B. Levy, M. Debouverie, G. Audibert et al., Reversal of late septic shock with supraphysiologic doses of hydrocortisone, Crit Care Med, vol.26, issue.4, pp.645-650, 1998.

C. L. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer et al., Hydrocortisone therapy for patients with septic shock, N Engl J Med, vol.358, issue.2, p.111, 2008.

W. I. Sligl, D. A. Milner, S. Sundar, W. Mphatswe, and S. R. Majumdar, Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis, Clin Infect Dis, vol.49, issue.1, pp.93-101, 2009.

G. P. Patel and R. A. Balk, Systemic steroids in severe sepsis and septic shock, Am J Respir Crit Care Med, vol.185, issue.2, pp.133-139, 2012.

S. Weber-carstens, D. M. Bercker, S. Dimroth, A. Ahlers, O. Kaisers et al., Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients, Intensive Care Med, vol.33, issue.4, pp.730-733, 2007.

J. Briegel, C. L. Sprung, D. Annane, M. Singer, D. Keh et al., Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock, Intensive Care Med, vol.35, issue.12, pp.2151-2157, 2009.

S. Meijvis, H. Hardeman, H. Remmelts, R. Heijligenberg, G. T. Rijkers et al., Dexamethasone and length of hospital stay in patients with communityacquired pneumonia: a randomised, double-blind, placebo-controlled trial, Lancet, vol.377, issue.9782, pp.2023-2053, 2011.

M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi et al., Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study, Am J Respir Crit Care Med, vol.171, issue.3, pp.242-250, 2005.

, Société de pathologie infectieuse de langue française, 17th Consensus conference. Consensus conference on bacterial meningitis, vol.39, pp.175-86, 2009.

C. Putensen, N. Theuerkauf, J. Zinserling, H. Wrigge, and P. Pelosi, Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury, Ann Intern Med, vol.151, issue.8, pp.566-576, 2009.

K. E. Burns, N. K. Adhikari, A. S. Slutsky, G. H. Guyatt, J. Villar et al., Pressure and volume limited ventilation for the ventilatory management of patients with acute lung injury: A systematic review and meta-analysis, PLoS One, vol.6, issue.1, p.14623, 2011.

D. N. Hager, J. A. Krishnan, D. L. Hayden, and R. G. Brower, Tidal volume reduction in patients with acute lung injury when plateau pressures are not high, Am J Respir Crit Care Med, vol.172, issue.10, pp.1241-1245, 2005.

M. B. Drakulovic, A. Torres, T. T. Bauer, J. M. Nicolas, S. Nogué et al., Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial, The Lancet, vol.354, issue.9193, pp.1851-1858, 1999.

B. H. Cuthbertson, C. L. Sprung, D. Annane, S. Chevret, M. Garfield et al., The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock, Intensive Care Med, vol.35, issue.11, pp.1868-76, 2009.

P. Jabre, X. Combes, F. Lapostolle, M. Dhaouadi, A. Ricard-hibon et al., Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial, Lancet Lond Engl, vol.374, issue.9686, pp.293-300, 2009.

A. J. Singer, J. Ng, H. C. Thode, R. Spiegel, and S. Weingart, Quick SOFA Scores Predict Mortality in Adult Emergency Department Patients With and Without Suspected Infection, Ann Emerg Med, vol.69, issue.4, pp.475-479, 2017.

C. W. Seymour, V. X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea et al., Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), Jama, vol.315, issue.8, pp.762-774, 2016.

A. Moskowitz, P. V. Patel, A. V. Grossestreuer, M. Chase, N. I. Shapiro et al., Quick sequential organ failure assessment and systemic inflammatory response syndrome criteria as predictors of critical care intervention among patients with suspected infection, Crit Care Med, vol.45, issue.11, pp.1813-1819, 2017.

Y. Freund, N. Lemachatti, E. Krastinova, M. Van-laer, Y. Claessens et al., Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department, Jama, vol.317, issue.3, pp.301-308, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01484589

S. Haydar, M. Spanier, P. Weems, S. Wood, and T. Strout, Comparison of qSOFA score and SIRS criteria as screening mechanisms for emergency department sepsis, Am J Emerg Med, vol.35, issue.11, pp.1730-1733, 2017.

B. O. Askim-\aasa, E. Sollig\a-ard, F. Moser, H. Stene, and J. K. Dam\a-as,

J. Wang, Y. Chen, S. Guo, X. Mei, and P. Yang, Predictive performance of quick Sepsisrelated Organ Failure Assessment for mortality and ICU admission in patients with infection at the ED, Am J Emerg Med, vol.34, issue.9, pp.1788-1793, 2016.

E. J. Giamarellos-bourboulis, T. Tsaganos, I. Tsangaris, M. Lada, C. Routsi et al., Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification, Clin Microbiol Infect, vol.23, issue.2, pp.104-113, 2017.

E. P. Raith, A. A. Udy, M. Bailey, S. Mcgloughlin, C. Macisaac et al., Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit, JAMA, vol.317, issue.3, pp.290-300, 2017.

I. Cortés-puch and C. S. Hartog, Opening the Debate on the New Sepsis DefinitionChange Is Not Necessarily Progress: Revision of the Sepsis Definition Should Be Based on New Scientific Insights, Am J Respir Crit Care Med, 2016.


S. Haydar, M. Spanier, P. Weems, S. Wood, and T. Strout, Comparison of qSOFA score and SIRS criteria as screening mechanisms for emergency department sepsis, Am J Emerg Med, vol.35, issue.11, pp.1730-1733, 2017.

F. R. Machado, R. Salomao, L. C. Pontes-de-acevedo, T. Lisboa, C. Filho et al., American Sepsis Institute (LASI). Why LASI did not endorse the new definitions of sepsis published today in JAMA, 2016.

S. Q. Simpson, New sepsis criteria: a change we should not make, CHEST J, vol.149, issue.5, pp.1117-1118, 2016.

J. Vincent, A. De-mendonca, F. Cantraine, R. Moreno, J. Takala et al., Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study, Crit Care Med, vol.26, issue.11, p.1793, 1998.

B. Khwannimit, A comparison of three organ dysfunction scores: MODS, SOFA and LOD for predicting ICU mortality in critically ill patients, J-Med Assoc Thail, vol.90, issue.6, p.1074, 2007.

D. P. Bota, C. Melot, F. L. Ferreira, V. N. Ba, and J. Vincent, The multiple organ dysfunction score (MODS) versus the sequential organ failure assessment (SOFA) score in outcome prediction, Intensive Care Med, vol.28, issue.11, pp.1619-1624, 2002.

V. Pettilä, M. Pettilä, S. Sarna, P. Voutilainen, and O. Takkunen, Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill, Crit Care Med, vol.30, issue.8, pp.1705-1711, 2002.

F. L. Ferreira, D. P. Bota, A. Bross, C. Mélot, and J. Vincent, Serial evaluation of the SOFA score to predict outcome in critically ill patients, Jama, vol.286, issue.14, pp.1754-1758, 2001.

U. Janssens, C. Graf, J. Graf, P. W. Radke, B. Königs et al., Evaluation of the SOFA score: a single-center experience of a medical intensive care unit in 303 consecutive patients with predominantly cardiovascular disorders, Intensive Care Med, vol.26, issue.8, pp.1037-1045, 2000.

B. Holtfreter, C. Bandt, S. Kuhn, U. Grunwald, C. Lehmann et al., Serum osmolality and outcome in intensive care unit patients, Acta Anaesthesiol Scand, vol.50, issue.8, pp.970-977, 2006.

K. M. Ho, K. Y. Lee, T. Williams, J. Finn, M. Knuiman et al., Comparison of Acute Physiology and Chronic Health Evaluation (APACHE) II score with organ failure scores to predict hospital mortality, Anaesthesia, vol.62, issue.5, pp.466-473, 2007.

P. Gosling, J. Czyz, P. Nightingale, and M. Manji, Microalbuminuria in the intensive care unit: Clinical correlates and association with outcomes in 431 patients, Crit Care Med, vol.34, issue.8, pp.2158-2166, 2006.

J. Timsit, J. Fosse, G. Troché, A. De-lassence, C. Alberti et al., Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients, Crit Care Med, vol.30, issue.9, 2002.

L. Minne, A. Abu-hanna, and E. De-jonge, Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care, vol.12, p.161, 2008.

C. R. Carpenter, S. M. Keim, S. Upadhye, and H. B. Nguyen, Group BE in EMI, others. Risk stratification of the potentially septic patient in the emergency department: the Mortality in the Emergency Department Sepsis (MEDS) score, J Emerg Med, vol.37, issue.3, pp.319-327, 2009.

N. I. Shapiro, R. E. Wolfe, R. B. Moore, E. Smith, E. Burdick et al., Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule*, Crit Care Med, vol.31, issue.3, pp.670-675, 2003.

C. C. Chen, C. F. Chong, Y. L. Liu, K. C. Chen, and T. L. Wang, Risk stratification of severe sepsis patients in the emergency department, Emerg Med J, vol.23, issue.4, pp.281-285, 2006.

M. D. Howell, M. W. Donnino, D. Talmor, P. Clardy, L. Ngo et al., Performance of severity of illness scoring systems in emergency department patients with infection, Acad Emerg Med, vol.14, issue.8, pp.709-714, 2007.

C. Lee, S. Chen, C. Tsai, S. Wu, W. Chiang et al., Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department, Shock, vol.29, issue.3, pp.322-327, 2008.

J. D. Sankoff, M. Goyal, D. F. Gaieski, K. Deitch, C. B. Davis et al., Validation of the Mortality in Emergency Department Sepsis (MEDS) score in patients with the systemic inflammatory response syndrome (SIRS)*, Crit Care Med, vol.36, issue.2, pp.421-426, 2008.

C. Alberti, C. Brun-buisson, S. Chevret, M. Antonelli, S. V. Goodman et al., Systemic inflammatory response and progression to severe sepsis in critically ill infected patients, Am J Respir Crit Care Med, vol.171, issue.5, pp.461-468, 2005.
DOI : 10.1164/rccm.200403-324oc

F. Rubulotta, J. C. Marshall, G. Ramsay, D. Nelson, M. Levy et al., Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis, Crit Care Med, vol.37, issue.4, p.1329, 2009.
DOI : 10.1097/ccm.0b013e31819d5db1

C. Granja, P. Póvoa, C. Lobo, A. Teixeira-pinto, A. Carneiro et al., The Predisposition, Infection, Response and Organ Failure (Piro) Sepsis Classification System: Results of Hospital Mortality Using a Novel Concept and Methodological Approach, PLOS ONE, vol.8, issue.1, p.53885, 2013.

Y. Chen and C. Li, Risk stratification and prognostic performance of the predisposition, infection, response, and organ dysfunction (PIRO) scoring system in septic patients in the emergency department: a cohort study, Crit Care, vol.18, p.74, 2014.

H. B. Nguyen, C. Van-ginkel, M. Batech, J. Banta, and S. W. Corbett, Comparison of Predisposition, Insult/Infection, Response, and Organ dysfunction, Acute Physiology And Chronic Health Evaluation II, and Mortality in Emergency Department Sepsis in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle, J Crit Care, vol.27, issue.4, pp.362-369, 2012.

S. P. Macdonald, G. Arendts, D. M. Fatovich, and S. G. Brown, Comparison of PIRO, SOFA, and MEDS scores for predicting mortality in emergency department patients with severe sepsis and septic shock, Acad Emerg Med, vol.21, issue.11, pp.1257-1263, 2014.

W. A. Knaus, J. E. Zimmerman, D. P. Wagner, E. A. Draper, and D. E. Lawrence, APACHE-acute physiology and chronic health evaluation: a physiologically based classification system, Crit Care Med, vol.9, issue.8, pp.591-597, 1981.

W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, APACHE II: a severity of disease classification system, Crit Care Med, vol.13, issue.10, pp.818-829, 1985.

W. A. Knaus, D. P. Wagner, E. A. Draper, J. E. Zimmerman, M. Bergner et al., The APACHE III prognostic system: risk prediction of hospital mortality for critically III hospitalized adults, Chest, vol.100, issue.6, pp.1619-1636, 1991.

J. E. Zimmerman, A. A. Kramer, D. S. Mcnair, and F. M. Malila, Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients, Crit Care Med, vol.34, issue.5, pp.1297-1310, 2006.
DOI : 10.1097/01.ccm.0000215112.84523.f0

J. Vincent and R. Moreno, Clinical review: Scoring systems in the critically ill. Crit Care, vol.14, p.207, 2010.

J. H. James, F. A. Luchette, F. D. Mccarter, and J. E. Fischer, Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. The lancet, vol.354, pp.505-508, 1999.

M. E. Mikkelsen, A. N. Miltiades, D. F. Gaieski, M. Goyal, B. D. Fuchs et al., Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock*, Crit Care Med, vol.37, issue.5, p.1670, 2009.

P. Marty, A. Roquilly, F. Vallée, A. Luzi, F. Ferré et al., Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 hours in Intensive Care Unit: an observational study. Ann Intensive Care, vol.3, p.3, 2013.

H. B. Nguyen, E. P. Rivers, B. P. Knoblich, G. Jacobsen, A. Muzzin et al., Early lactate clearance is associated with improved outcome in severe sepsis and septic shock, Crit Care Med, vol.32, issue.8, pp.1637-1642, 2004.

R. C. Arnold, N. I. Shapiro, A. E. Jones, C. Schorr, J. Pope et al., Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis, Shock, vol.32, issue.1, pp.35-39, 2009.

H. B. Nguyen, W. S. Kuan, M. Batech, P. Shrikhande, M. Mahadevan et al., Outcome effectiveness of the severe sepsis resuscitation bundle with addition of lactate clearance as a bundle item: a multi-national evaluation, Crit Care, vol.15, issue.5, p.229, 2011.

C. Wacker, A. Prkno, F. M. Brunkhorst, and P. Schlattmann, Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis, Lancet Infect Dis, vol.13, issue.5, pp.426-435, 2013.

C. Venet, B. Tardy, and F. Zéni, Marqueurs biologiques de l?infection en réanimation chez l?adulte: place de la procalcitonine, Réanimation, vol.11, issue.3, pp.156-171, 2002.

D. Anand, S. Das, S. Bhargava, L. M. Srivastava, A. Garg et al., Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study, J Crit Care, vol.30, issue.1, pp.218-225, 2015.

E. J. Giamarellos-bourboulis, P. Giannopoulou, P. Grecka, D. Voros, K. Mandragos et al., Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?, J Crit Care, vol.19, issue.3, pp.152-157, 2004.

P. Hausfater, S. Garric, S. B. Ayed, M. Rozenheim, M. Bernard et al., La procalcitonine: marqueur idéal des infections systémiques? Étude prospective dans un service d'accueil des urgences, Rev Médecine Interne, vol.22, p.441, 2001.

P. Schuetz, M. Christ-crain, R. Thomann, C. Falconnier, M. Wolbers et al., Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial, Jama, vol.302, issue.10, pp.1059-1066, 2009.

P. Hausfater, Biomarkers and infection in the emergency unit, Médecine Mal Infect, vol.44, issue.4, pp.139-145, 2014.

Y. Arai, K. Yamashita, K. Mizugishi, and A. Takaori-kondo, Presepsin (soluble CD14 subtype) Is Secreted from Human Monocytes after Phagocytosis ? in Vitro Analyses and a Retrospective Cohort Study in Patients with Allogeneic Stem Cell Transplantation, Blood, vol.124, issue.21, pp.1402-1402, 2014.

Y. Okamura and H. Yokoi, Development of a point-of-care assay system for measurement of presepsin (sCD14-ST), Clin Chim Acta, vol.412, issue.23?24, pp.2157-61, 2011.

Y. Yaegashi, K. Shirakawa, N. Sato, Y. Suzuki, M. Kojika et al., Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis, J Infect Chemother, vol.11, issue.5, pp.234-238, 2005.

E. Spanuth, B. Ivandic, H. Ebelt, and K. Werdan, The new sepsis marker presepsin is superior for prognosis and disease monitoring compared to procalcitonin, Biochim Clin, vol.37, p.150, 2013.

H. Ishikura, T. Nishida, A. Murai, Y. Nakamura, Y. Irie et al., New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective singlecenter observational study, Crit Care, vol.18, issue.1, p.19, 2014.

J. Rabensteiner, M. Skvarc, M. Hoenigl, J. Osredkar, F. Prueller et al., Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome, J Infect, vol.69, issue.6, pp.627-657, 2014.

G. Romualdo-lg-de, P. E. Torrella, M. V. González, R. J. Sánchez, A. H. Holgado et al., Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department, Clin Biochem, vol.47, issue.7?8, pp.505-513, 2014.

T. Shozushima, G. Takahashi, N. Matsumoto, M. Kojika, Y. Okamura et al., Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome, J Infect Chemother, vol.17, issue.6, pp.764-769, 2011.

S. Endo, Y. Suzuki, G. Takahashi, T. Shozushima, H. Ishikura et al., Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study, J Infect Chemother, vol.18, issue.6, pp.891-897, 2012.

M. Ulla, E. Pizzolato, M. Lucchiari, M. Loiacono, F. Soardo et al., Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study, Crit Care, vol.17, issue.4, p.168, 2013.

S. Masson, P. Caironi, C. Fanizza, R. Thomae, R. Bernasconi et al., Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial, Intensive Care Med, vol.41, issue.1, pp.12-20, 2014.

M. Behnes, T. Bertsch, D. Lepiorz, S. Lang, F. Trinkmann et al., Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment, Crit Care, vol.18, issue.5, p.507, 2014.

T. H. Abdallah, E. M. El-reweny, M. M. El-sawy, and M. M. Aboudeif, Prognostic value of presepsin (soluble cd14 subtype) in critically ill patients with severe sepsis and septic shock, Life Sci J, vol.12, issue.1, 2015.

B. Liu, Y. Chen, Q. Yin, Y. Zhao, and C. Li, Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department, Crit Care, vol.17, issue.5, p.244, 2013.

S. Masson, P. Caironi, E. Spanuth, R. Thomae, M. Panigada et al., Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial, Crit Care, vol.18, issue.1, p.6, 2014.

E. Spanuth, H. Ebelt, B. Ivandic, and K. Werdan, Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin, Adv Clin Chem Lab Med, vol.128, 2012.

S. Endo, Y. Suzuki, G. Takahashi, T. Shozushima, H. Ishikura et al., Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study, J Infect Chemother, vol.20, issue.1, pp.30-34, 2014.

C. Pierrakos, J. Vincent, M. Walther, P. S. Leonec, J. Barie et al., Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: Results from the EPIC II study, Sepsis biomarkers: a review. Crit Care, vol.14, 2007.

G. Anaïs, Evaluation de la prescription du dosage sanguin de la procalcitonine dans la structure des urgences de Mercy, 2015.

, Annexes Annexe 1 : Algorithme diagnostique de CIVD proposé par l'ISTH

C. Evaluer-le-risque-de, Le patient a-t-il une pathologie susceptible d'être associée à une CIVD ?

?. Si,

?. Si-non,

, Prescrire les tests de coagulation globaux : Numération Plaquettaire, Temps de Quick, Fibrinogène, Monomères de Fibrine (FM) ou Produits de Dégradation de la Fibrine

, Déterminer le score relatif au résultat de chaque paramètre de coagulation : ? Plaquettes : > 100 G/L : 0-< 100 G/L : 1-< 50 G/L : 2 ? Augmentation des taux de marqueurs relatifs à la Fibrine

, Additionner les différents résultats

, Analyser le score final : ? Si score ? 5 : compatible avec une CIVD patente. Dans ce cas, répéter les analyses quotidiennement et recalculer le score ? Si score < 5 : suggère (n'affirme pas) une CIVD latente